We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000725:SZSEHyundai Engineering & Construction Co.,Ltd. Analysis

Data as of 2026-06-22 - not real-time

₩54,500.00

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

The stock is trading below its short‑ and medium‑term moving averages, with the 20‑day SMA sitting above the current price and the 50‑day SMA even higher. Momentum indicators show a modestly bullish MACD histogram while the RSI hovers in the low‑forties, suggesting limited upside momentum but no immediate oversold condition. Support sits a few thousand points below the market price, and resistance lies well above, framing a range‑bound outlook in the near term.
Fundamentally, the company reports a sharp revenue decline, thin margins and negative operating and free cash flow, compounded by a high debt load relative to equity. Although a dividend yield near one and a half percent is offered, the payout comes from limited earnings and cash reserves, raising questions about its durability. The balance sheet stress and earnings weakness outweigh the modest income from the dividend.
Risk factors are pronounced: volatility is elevated, beta is modestly below the market, and the construction sector is inherently cyclical and sensitive to regulatory approvals. Geographic diversification across emerging regions adds geopolitical and currency exposure, while decreasing trading volumes point to liquidity constraints. These elements collectively suggest a cautious stance despite a low price‑to‑sales multiple.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • price near technical support
  • moderate bullish MACD signal
  • declining trading volume

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • persistent revenue contraction
  • high leverage and negative cash flow
  • questionable dividend sustainability

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • structural debt burden
  • cyclical industry exposure
  • lack of clear earnings recovery path

Key Metrics & Analysis

Financial Health

Revenue Growth-15.80%
Profit Margin1.43%
ROE5.76%
ROA1.19%
Debt/Equity38.36
Op. Cash Flow₩-1138732040192
Free Cash Flow₩-1391086927872
Industry P/E31.4

Technical Analysis

TrendNeutral
RSI40.1
Support₩49,700.00
Resistance₩68,400.00
MA 20₩56,880.00
MA 50₩66,754.00
MA 200₩61,197.50
MACDBullish
VolumeDecreasing
Fear & Greed Index91.13

Valuation

GradeUndervalued
TypeValue
Dividend Yield1.57%

Risk Assessment

Beta0.90
Volatility59.05%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.